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CONSPECTUS: Multidomain peptides (MDPs) are a class of self-assembling peptides that are organized in a β-sheet motif,
resulting in a nanoﬁbrous architecture. This structure is stabilized by hydrophobic packing in the ﬁber core and a hydrogen-
bonding network down the ﬁber long axis. Under easily controllable conditions, regulated by electrostatic interactions between
the peptides and the pH and salt composition of the solvent, the nanoﬁber length can be dramatically extended, resulting in ﬁber
entanglement and hydrogel formation. One of the chief strengths of this supramolecular material is that the design criteria
governing its structure and assembly are robust and permit a wide range of modiﬁcations without disruption. This allows the
MDPs to be tailored to suit a wide range of applications, particularly in biomedical engineering. For example, delivery of small
molecules, proteins, and cells is easily achievable. These materials can be trapped within the matrices of the hydrogel or trapped
within the hydrophobic core of the nanoﬁber, depending on the cargo and the design of the MDP. Interactions between the
nanoﬁbers and their cargo can be tailored to alter the release proﬁle, and in the most sophisticated cases, diﬀerent cargos can be
released in a cascading time-dependent fashion. The MDP hydrogel and its cargo can be targeted to speciﬁc locations, as the
thixotropic nature of the hydrogel allows it to be easily aspirated into a syringe and then delivered from a narrow-bore needle.
The sequence of amino acids making up the MDP can also be modiﬁed to permit cross-linking or enzymatic degradation.
Selection of sequences with or without these modiﬁcations allows one to control the rate of degradation in vivo from as rapidly as
1 week to well over 6 weeks as the MDP nanoﬁbers are degraded to their amino acid components. MDP sequences can also be
modiﬁed to add biomimetic sequences derived from growth factors and other signaling proteins. These chemical signals are
displayed at a very high density on the ﬁbers’ surface, where they contribute to the modiﬁcation of cellular behavior. We have
used this approach to drive blood vessel formation, which is critical for tissue regeneration generally and more speciﬁcally for the
treatment of diseases related to poor blood ﬂow. MDPs represent an ideal case of bottom-up design where control of chemical
structure leads to control of self-assembly and nanostructure and thereby control of material properties that collectively can
control biological function.
■ INTRODUCTION
While primarily composed of water, hydrogels can be prepared
from both natural and synthetic materials, including both small
molecules and polymers. Perhaps the most complex hydrogel of
all is the extracellular matrix (ECM), which plays a critical role
in determining tissue architecture and cellular behavior.
Because the ECM has a large role in cell adhesion, cell survival,
cell proliferation, cell signaling, cell diﬀerentiation, and
nutrient/waste exchange, many attempts have been made to
mimic its structure, materials properties, and ultimately its
function. Among these attempts, peptide hydrogels1 and
peptide-derivatized hydrogels2 have been particularly successful.
While peptide hydrogels can utilize various structural motifs to
drive supramolecular assembly and hydrogel formation, perhaps
the most explored category for tissue regeneration purposes is
the β-sheet peptide hydrogel. Several β-sheet hydrogels have
been developed, synthesized, and characterized for biomedical
applications, including multidomain peptides (MDPs) devel-
oped by our lab. Other key examples include peptide
amphiphiles from the Stupp lab,3 RADA-16 and derivatives
from the Zhang lab,4 and β-hairpin peptides from the Schneider
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and Pochan labs.5 This Account does not discuss all of the β-
sheet peptide hydrogels proposed in the literature but rather
presents the development of self-assembling MDP hydrogels by
our lab. We recommend several reviews that present broader
perspectives on peptide-based and other hydrogels.1,6−10
For the past decade, our lab has worked to engineer a class of
self-assembling peptide hydrogels that we call multidomain
peptides. With solely the 20 naturally occurring amino acids as
building blocks, these peptides are synthesized using standard
solid-phase chemistry and require no special functionality for
supramolecular assembly or hydrogelation. By relying on
principles of supramolecular chemistry, we have designed this
class of β-sheet peptides to self-assemble into nanoﬁbers using
the composition of the aqueous solution as the trigger for
assembly. The design of the peptide primary sequence enables
cross-linking of peptide nanoﬁbers either ionically or covalently
to induce hydrogelation. The MDP hydrogel has demonstrated
great promise as a bioengineering scaﬀold, as the triggering
conditions for peptide self-assembly and cross-linking are
compatible with physiological conditions. We have demon-
strated that the MDP hydrogel is biocompatible with multiple
cell types, can be used to eﬀectively deliver cells or various
types of bioactive molecules, and can be altered to include
bioactive amino acid sequences that direct cell behavior.
Through simple changes in the chemical sequence of the
peptide, we can dictate the formation of nanoﬁbers through
self-assembly, the formation of a hydrogel through entangle-
ment of the formed ﬁbers, and the mechanical properties of the
formed hydrogel. Ultimately, this allows us to also dictate the in
vivo response to the MDP hydrogel through a combination of
these properties and associated biological signals encapsulated
within the hydrogel or incorporated into the assembling
peptide. In principle, therefore, engineering of the MDP
primary sequence allows for manipulation of the scaﬀold to suit
any speciﬁc biological application. While other related peptide
hydrogels have some of these features, the combination of all of
them make MDPs uniquely suited to biological applications.
■ PART 1: PEPTIDE DESIGN
Initial studies performed by our laboratory revealed how the
peptide sequence can be designed to allow for the supra-
molecular assembly of individual peptides to form ﬁbers. All
MDPs exhibit the same general chemical design, with the core
of the peptide consisting of alternating hydrophilic and
hydrophobic amino acids and the termini of the peptide
consisting of charged amino acids (Figure 1A,B).11 As shown in
Figure 1A and SI Table 1, we have investigated a variety of
diﬀerent amino acids to compose each motif within the MDP.
By using glutamate or lysine as the charged terminal residues,
we have generated peptides with net negative or positive
charge, respectively.12 Hydrophilic residues have included
glutamine, serine, threonine, and cysteine, while hydrophobic
residues have included both aliphatic and aromatic side
chains.11−14 Regardless of the speciﬁc amino acids selected to
compose the peptide, the chemical design of the MDP causes
these peptides to adopt a β-sheet secondary structure with
hydrophobic residues on one face of the peptide and
hydrophilic residues on the other. Arising from the alternating
hydrophilic and hydrophobic residues in the core of the MDP,
this facial amphiphile is key for the supramolecular assembly of
peptides to form nanoﬁbers.
Because of the amphiphilic nature of MDPs, they self-
assemble to form nanoﬁbers in aqueous solution. Each ﬁber
consists of a bilayer of peptides with the hydrophilic peptide
faces exposed to the surrounding aqueous solution and the
hydrophobic peptide faces sequestered into the core of the
MDP. Intellectually, it is convenient to divide the ﬁbers into
repeating units to understand why MDPs undergo supra-
molecular assembly. We call the repeating unit of the MDP
nanoﬁber a “hydrophobic sandwich”, and it comprises four
peptides (Figure 1C).15 In this sandwich, the hydrophobic faces
of the MDPs pack against one another to minimize contact
with surrounding water molecules. When aligned, hydrogen
bonding between adjacent peptide backbones can occur, further
stabilizing the assembled peptides (Figure 1D). Our lab has also
discovered methods of deﬁning the peptide orientation within
the nanoﬁbers, speciﬁcally the formation of parallel or
antiparallel hydrogen-bonding networks. For instance, most
MDPs contain leucine residues as their hydrophobic core, and
all of these sequences exhibit antiparallel packing of the β-sheet
peptides.11−14,16,17 However, by the use of tryptophan or
tyrosine in place of leucine, it is possible to change this
Figure 1. Self-Assembly of MDPs. (A) General composition of MDPs.
(B) Primary sequence of an example MDP, K2(SL)6K2. (C) Repeating
unit of the MDP nanoﬁber. (D) Depiction of an MDP nanoﬁber. (E)
Vitreous ice cryo-TEM image of the self-assembled MDP K2(QL)6K2
before the addition of counterions. (C, D) Adapted with permission
from ref 15. Copyright 2014 Elsevier. (E) Reprinted from ref 11.
Copyright 2007 American Chemical Society.
Accounts of Chemical Research Article
DOI: 10.1021/acs.accounts.6b00553
Acc. Chem. Res. 2017, 50, 714−722
715
orientation to parallel packing of the peptides. Modeling
suggests that this is the case because the side chains of these
two amino acids form stronger interactions in the hydrophobic
sandwich when ﬁbers self-assemble in a parallel rather than
antiparallel fashion, thus deﬁning the hydrogen-bonding
orientation.14 While not mechanistic in nature, the idea of
the hydrophobic sandwich illustrates the concepts driving self-
assembly of MDPs. Theoretical studies by other groups have
also been performed in attempts to elucidate the actual step-by-
step process of peptide assembly.18 Regardless of the
mechanism of supramolecular assembly, the ﬁnal result is a
nanoﬁber, exhibiting the width of the peptide sequence, the
height of the MDP dimer, and “inﬁnite” length after charge
screening (Figure 1E).11 To characterize MDPs, we conﬁrm
successful synthesis using mass spectrometry; the secondary
structure using circular dichroism spectroscopy and infrared
spectroscopy; self-assembly using atomic force microscopy,
scanning electron microscopy, and/or transmission electron
microscopy; and hydrogel formation using oscillatory rheology.
With the goal of creating self-assembled nanoﬁbrous
structures while maintaining solubility, the proper balance of
charged residues to hydrophilic−hydrophobic residue repeats
was determined experimentally. Through circular dichroism
(CD) spectroscopy and transmission electron microscopy
(TEM), it was found that multidomain peptides typically
require at least 3 times more hydrophilic−hydrophobic repeats
than charged residues to form nanoﬁbers.11 When too few
charged residues are included in the design, the peptides have
very poor solubility and are diﬃcult to handle and purify.
However, if the peptide contains too many charged residues,
ﬁbers fail to form as a result of like-charge repulsion at the
peptide termini. In terms of hydrophilic−hydrophobic amino
acid repeats, a peptide without a suﬃcient number will either
fail to form ﬁbers or form ﬁbers contaminated with amorphous
aggregates of assembled peptides. By properly balancing the
number of charged residues with the number of hydrophilic−
hydrophobic residue repeats, it is possible to consistently obtain
self-assembled nanoﬁbers of relatively uniform length and
diameter (Figure 1E).
MDPs are further engineered at the primary sequence level
to allow for simple and biologically compatible hydrogelation
through cross-linking of peptide nanoﬁbers (Figure 2A,B). The
inclusion of charged residues at the peptide termini serves two
purposes: ﬁrst, to increase the solubility, and second, to enable
non-covalent cross-linking between peptide ﬁbers. In aqueous
solution, the charged residues at the peptide termini oppose
ﬁber self-assembly; however, the addition of multivalent
oppositely charged salts triggers hydrogelation by using these
charged residues as locations to cross-link ﬁbers. For positively
charged peptides, we typically use a phosphate buﬀer for cross-
linking, while a magnesium or calcium salt is appropriate for
cross-linking of negatively charged peptides. Monovalent salts
such as NaCl also work but require much higher concen-
trations. If desired for a speciﬁc application, it is also possible to
cross-link peptides using drug molecules of the appropriate
charge.19 Signiﬁcantly, these non-covalent interactions are
capable of reformation after disruption, allowing the MDP
hydrogel to be a thixotropic material that liqueﬁes under a
shearing force and regels when the shearing force ceases. We
have demonstrated this using oscillatory rheology. When a
shearing force is applied, the storage and loss moduli invert,
signifying liquiﬁcation. Following removal of the shearing force,
the storage and loss moduli recover to approximately 75% of
their initial values nearly immediately and to 100% over 15 min
Figure 2. (A) Various methods to cross-link MDPs using non-covalent or covalent interactions. (B) Cross-linking results in a clear hydrogel. (C)
Shear recovery of the MDP hydrogel. At time = −1, a shearing force is applied to liquefy the hydrogel, and at time = 0 the shearing force is released.
(D) Strain sweep analysis of a covalently cross-linked MDP hydrogel vs a non-covalently cross-linked MDP hydrogel. Adapted from refs 12 and 29.
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(Figure 2C). In practical terms, the ability to shear thin and
shear recover is an extremely valuable property of the MDP
hydrogel, as it enables the material to be easily delivered via
injection. We have relied on this property for several of our
biological studies, and we have successfully delivered the MDP
hydrogel using as small as a 33 gauge needle.20
While our lab most commonly uses non-covalent cross-
linking with salt solutions to trigger hydrogelation, we have
extensively investigated other methods of cross-linking as well.
With the motivation of manipulating the rheological properties
of the MDP hydrogel, we have studied covalent cross-linking of
peptide nanoﬁbers. Because covalent cross-linking forms
stronger interactions between peptide ﬁbers, a dramatic
increase in storage modulus is observed for covalently cross-
linked MDP hydrogels.12,21 One method of covalent cross-
linking uses cysteine residues as hydrophilic amino acids in the
core of the MDP. For this strategy, general oxidation results in
intraﬁber and interﬁber covalent disulﬁde bonds. The disulﬁde
bonds formed between two cysteine residues result in a
dramatic increase in gel storage modulus (Figure 2D).12 It is
also possible to utilize enzymes to covalently cross-link peptide
ﬁbers. For instance, lysyl oxidase is an enzyme found in nature
that functions to cross-link ECM components. In nature, it acts
by oxidizing an amine to an aldehyde, which can then react with
another amine to form a Schiﬀ base or undergo an aldol
condensation reaction with another aldehyde. In our system,
lysyl oxidase acts on the lysine side chains of the MDP and
covalently cross-links peptide nanoﬁbers. This increases the
storage modulus by over an order of magnitude in comparison
to the non-covalently cross-linked system of the same MDP.21
While MDPs are relatively short in length, typically between
18 and 30 amino acids, careful selection of these amino acids
results in the desired chemical and mechanical properties.
Alternation of hydrophilic and hydrophobic residues drives β-
sheet formation in either a parallel or antiparallel orientation.
Charged residues at the peptide termini determine the overall
scaﬀold charge and therefore which molecules can be used to
non-covalently cross-link the peptide nanoﬁbers. To inﬂuence
the mechanical properties, non-covalent or covalent cross-
linking can be used. Through the design of the peptide primary
sequence, we have created a self-assembling nanoﬁbrous
scaﬀold capable of delivery via syringe injection.
■ PART 2: LOADED HYDROGELS
The ﬁbrous nanostructure of the MDP enables these hydrogels
to be eﬀective vehicles for culture and/or delivery of cells and
other bioactive molecules. During formation of the hydrogel,
these substances can easily be included, resulting in a 3D
injectable hydrogel containing the substance of interest.
Because of diﬀerences in relative size, cells tend to remain
trapped within the MDP ﬁbrous matrix, while molecules
typically diﬀuse out of the hydrogel. Because of this, the MDP
hydrogel can serve as an eﬀective material to evaluate cell
behavior in a 3D environment, and this constitutes an
important advantage because there is wide consensus in the
literature that cell behavior diﬀers drastically in 2D and 3D
culture methods.22 We have completed several studies with a
variety of cell types, such as stem cells and monocytes, to
conﬁrm the biocompatibility of the MDP hydrogel and evaluate
cell behavior in 2D versus 3D culture (Figure 3A and SI Table
2). For many cell types, the MDP hydrogel suggests a high level
of biocompatibility, showing cell adhesion to the scaﬀold, cell
proliferation, and adoption of characteristic cell morphology.
In addition to cell culture and delivery, we have also
evaluated the potential for the MDP hydrogel to eﬀectively
carry and deliver hydrophilic bioactive molecules. We have
previously published MDP release data for a wide variety of
bioactive molecules, including IL-4,23 MCP-1,23,24 VEGF,25
TGFβ1,25 FGF2,25 PlGF-1,24 EGF,24 and batroxobin,26 but in
theory the MDP hydrogel could be used to deliver virtually any
bioactive molecule. The motivations driving diﬀerent release
studies vary greatly; we have examined treatment of
perioperative bleeding, kidney injury, and tooth decay (Figure
3B), modulation of inﬂammation (Figure 3C), and promotion
of angiogenesis.17,23−28 While the biological applications of
these studies diﬀer signiﬁcantly, the results consistently show
that the MDP hydrogel can eﬀectively load and release
bioactive molecules and that these molecules remain functional
and are able to provoke a biological response after delivery. For
reasons not yet entirely understood, the release rates of
molecules from the hydrogel diﬀer depending on molecule
identity. For instance, MCP-1 exhibits burst release from the
MDP hydrogel, while release of IL-4 is sustained over a few
weeks.23 We have speculated that hydrodynamic volume or
molecular mass play a role in deﬁning the release proﬁle, but
other factors such as speciﬁc binding interactions must also
impact the release kinetics.
Figure 3. (A) Confocal images of stem cells from human deciduous teeth (SHED) cells after 11 days of 3D culture in K2(SL)6K2 hydrogel. Cell
nuclei are stained with DAPI and appear blue, while the actin cytoskeleton is stained with AlexaFluor 488 and appears green. Reprinted from ref 13.
Copyright 2014 American Chemical Society. (B) H&E image of pulplike tissue formed with concurrent delivery of dental pulp stem cells (DPSCs)
and the growth factors VEGF, TGFβ1, and FGF2. Reprinted with permission from ref 25. Copyright 2012 Mary Ann Liebert, Inc. (C)
Immunohistological analysis of a subcutaneous K(SL)3RG(SL)3KGRGDS hydrogel excised 1 week after implantation. Cell nuclei appear blue,
CCR7+ appear green, CD163+ appear purple, and CD68+ appear red. Reprinted with permission from ref 23. Copyright 2015 Elsevier.
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Changes in MDP primary sequence can also be used to
engineer the types of molecules that can be eﬀectively loaded
and delivered by the MDP hydrogel. Because the MDP design
incorporates charged, hydrophilic, and hydrophobic amino
acids, we are able to deliver molecules of varying polarity. In
some ways this is counterintuitive, as a hydrogel is by deﬁnition
aqueous and therefore should be more suited to deliver
hydrophilic molecules. However, each MDP ﬁber contains a
hydrophobic core, and hydrophobic molecules can be
successfully encapsulated within MDP ﬁbers. Thus, hydrophilic
molecules are encapsulated external to the MDP ﬁbers, while
hydrophobic molecules are encapsulated within the actual
MDP ﬁber itself (Figure 4A,B). To allow for encapsulation of
hydrophobic molecules, we engineered a gap into the core of
the MDP, and we refer to this design as the “missing-tooth”
model (Figure 4C,D).29 Essentially, one or two of the leucine
residues in the core of the peptide is altered to an alanine
residue. Because alanine has a smaller side chain than leucine,
this creates space along the core of the MDP ﬁber into which
hydrophobic materials can be successfully loaded while not
preventing ﬁber formation or gelation. For instance, the
unmodiﬁed K2(SL)6K2 hydrogel has a storage modulus of
191 Pa, and the storage moduli of the K2(SL)2SA(SL)3K2 and
K2(SL)2(SA)2(SL)2K2 hydrogels are each roughly equivalent at
142 and 158 Pascals, respectively.29 We have demonstrated
hydrophobic loading and delivery using SN-38, diﬂunisal, and
etodolac, which suggests that this strategy should allow for the
entrapment and delivery of virtually any appropriately sized
molecule with poor water solubility (Figure 4E).29
In addition to deﬁning the types of materials that can be
delivered by the MDP hydrogel, it is also possible to alter the
MDP hydrogel structure to engineer the release rate of
encapsulated materials. To accomplish this, our lab has
introduced an othogonal level of supramolecular assembly by
incorporating liposomes into the MDP hydrogel (Figure 5A,B).
Liposomes and peptide nanoﬁbers are distinct supramolecular
assemblies, but they can be mixed together without interrupting
the integrity of either structure (Figure 5C).24 Furthermore,
this design engineers a system for biphasic release of molecules
from the MDP hydrogel. Material loaded inside the MDP
hydrogel but outside the liposomes is released more rapidly
than material loaded inside the liposomes. This is the case
because liposomal degradation takes time to occur and has to
take place prior to diﬀusion of material from the MDP
hydrogel. We have demonstrated the proof of concept by
loading PlGF-1, MCP-1, and EGF either into liposomes or
directly into the MDP; when loaded into liposomes, all three
molecules show a sigmoidal release proﬁle, while direct loading
into the MDP hydrogel results in burst release (Figure 5D).24
Biologically speaking, the capability of biphasic release has
important implications in the applicability of MDP hydrogels.
Most biological processes involve signaling molecules released
Figure 4. (A, B) Typical repeating unit of an MDP that results in fast
release of drugs. (C, D) Missing-tooth MDP repeating unit allowing
for drug encapsulation in the nanoﬁber core and resulting in prolonged
release. (E) Data showing rapid release of etodolac from PBS (black),
slower release of etodolac from the K2(SL)6K2 hydrogel, and
prolonged release from the missing-tooth K2(SL)2SA(SL)3K2 hydro-
gel. Adapted from ref 29. Copyright 2016 American Chemical Society.
Figure 5. (A) Schematic showing self-assembly of peptide hydrogels
with growth factors loaded inside of liposomes. (B) Schematic of self-
assembly with one growth factor loaded inside of liposomes and
another loaded into the MDP hydrogel. (C) Cryo-TEM image of the
liposome−MDP composite hydrogel. (D) Release of PlGF-1 directly
from the hydrogel (blue) and release of EGF from liposomes
encapsulated within the hydrogel (red). Adapted from ref 24.
Copyright 2014 American Chemical Society.
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in a speciﬁc temporal order, and we have engineered a scaﬀold
capable of delivering materials in a temporally distinct manner
by creating these liposome−MDP composite hydrogels.
The design of the peptide primary structure ultimately results
in a 3D material capable of eﬀectively delivering and releasing
bioactive molecules and supporting cell viability. Although our
studies have involved a variety of diﬀerent cell types, bioactive
molecules, and applications, the supramolecular engineering of
MDPs to form nanoﬁbrous hydrogels is collectively responsible
for eﬀective loading and delivery. While the base MDP
hydrogel is capable of delivering water-soluble materials, small
alterations in the peptide primary structure allow for MDP-
based delivery of hydrophobic molecules as well. Furthermore,
temporal control over material delivery can be achieved
through incorporating additional structures within the hydrogel
matrix. Importantly, delivering materials using MDP hydrogels
preserves the bioactivity of molecules and vitality of cells and
oﬀers a method for localized application through injection.
■ PART 3: BIOACTIVITY AND BIOMIMICRY
While MDP hydrogels can be designed to eﬀectively deliver
exogenous growth factors, cytokines, and drug molecules, these
materials can also be synthesized to have distinct biofunction-
ality of their own through alteration of the peptide primary
sequence. Researchers have identiﬁed short bioactive amino
acid sequences, typically derived from biological molecules, that
are capable of initiating speciﬁc responses from cells. Because of
the modular nature of solid-phase peptide synthesis, these short
sequences can easily be attached to the termini of the MDP and
in some cases incorporated into the middle of the MDP
sequence. Because of the robust and well-understood assembly
of MDPs, the incorporation of these types of short signaling
motifs can typically be accomplished without interrupting the
characteristic and desirable properties of MDP hydrogels, such
as their ﬁbrous nanostructure and rheological properties. For
example, our lab has investigated MDPs designed to promote
cell adhesion, aid in material degradation, and drive angio-
genesis.
In order to preserve vitality and other basic cellular functions,
many cell types require adherence to their environment, the
ECM. Because the MDP hydrogel mimics the native ECM in
terms of its ﬁbrous nanoscale structure, cells are capable of
adhering to the MDP ﬁbers; furthermore, this response by cells
can be stimulated through the addition of a bioactive amino
acid sequence speciﬁcally designed to aid in cell adhesion.
Derived from the ECM protein ﬁbronectin, RGD has been
widely cited for its ability to increase cellular adhesion to
biomaterial scaﬀolds both in vitro and in vivo. We have
incorporated this sequence at the C-terminus of the base MDP
and evaluated its impact on the responsiveness of cells to the
matrix.13,17,20,25 In in vitro experiments, we have found that
inclusion of RGD promotes cell viability, spreading, and
proliferation, suggesting increased vitality of cells in the
bioactive scaﬀold (Figure 6).13,25
Gel responsiveness to cellular degradation signals can also be
engineered into MDP hydrogels through manipulation of the
peptide primary sequence. Cellular remodeling of the ECM is a
common occurrence in healthy tissue, and the remodeling of
scaﬀolding materials into healthy, functional tissue constitutes
the ultimate goal in our tissue engineering strategy. Therefore, a
successful MDP hydrogel will be responsive and susceptible to
cellular cues for material degradation, and we have engineered
this property into MDP hydrogels by including the short amino
acid sequence LRG. Without major disruption of the material
and handling properties, this sequence has been incorporated
into the core of the MDP to allow for scission of the peptide
bond by the enzyme matrix metalloprotease-2.25 After treat-
ment with MMP-2, cryo-TEM shows that MDP ﬁbers
containing the LRG sequence are degraded into amorphous
aggregates, while the ﬁbers of peptides without the LRG motif
remain intact (Figure 7A,B).16 In both in vitro and in vivo
environments, cells secrete MMP-2 as they attempt to degrade
Figure 6. Confocal microscopy images of stem cells from human
exfoliated deciduous teeth (SHED) after 11 days of 3D culture in (A)
K2(TL)6K2 and (B) K2(TL)6K2GRGDS. Cell nuclei are stained with
DAPI and appear blue, while the actin cytoskeleton is stained with
AlexaFluor 488 phalloidin and appears green. Adapted from ref 13.
Copyright 2014 American Chemical Society.
Figure 7. (A, B) Cryo-TEM images of K(SL)3RG(SL)3K nanoﬁbers
showing nanoﬁber degradation (A) before and (B) after incubation
with MMP-2. (C, D) Cell Tracker Green-labeled SHED cells cultured
in a monolayer on top of a K2(SL)6K2GRGDS hydrogel after (C) 1
day and (D) 5 days of culture. (E, F) Cell Tracker Green-labeled
SHED cells cultured in a monolayer on top of a K(SL)3RG-
(SL)3KGRGDS hydrogel after (E) 1 day and (F) 5 days of culture.
Adapted from ref 16. Copyright 2010 American Chemical Society.
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and remodel the MDP hydrogel, and the responsiveness of the
hydrogel to cellular cues stimulating degradation has important
consequences for cellular viability and function. We have shown
that cells grown in a monolayer on top of the MDP hydrogel
are able to migrate into the hydrogel only when the LRG motif
is present (Figure 7C−F).16 This has signiﬁcant implications
for tissue regeneration strategies, where inﬁltration of host cells
is imperative for success.
Incorporation of either a cell adhesion motif or an enzymatic
cleavage domain serves to create an environment more
amenable for cellular functions such as proliferation and matrix
remodeling. Essentially, by inclusion of these amino acids the
scaﬀold has been designed at the primary sequence level to
respond to the cells’ needs and the cues received by cells. In
contrast, MDPs can also incorporate bioactive sequences to
actively induce a desired cellular process. Through attachment
of short bioactive amino acid sequences derived from growth
factors, the MDP hydrogel itself can actually bind to and
activate cell-surface receptors. While proteins are large and
structurally complex molecules, several research groups have
sought to identify speciﬁc regions of proteins responsible for
activation of their target receptors. One speciﬁc growth factor
mimic of vascular endothelial growth factor (VEGF) has been
attached to the C-terminus of the MDP during peptide
synthesis. This particular MDP, which we call SLanc, includes
both the VEGF mimic to promote angiogenesis and the MMP-
2 cleavage site to promote scaﬀold degradation.
Chemical and material characterization of SLanc demon-
strates that this mimic can be attached to the MDP without
preventing supramolecular assembly, ﬁber formation, or
hydrogelation, suggesting MDP ﬂexibility and tolerance of
relatively lengthy mimic sequences. Despite incorporation into
the MDP sequence, the VEGF mimic sequence retains its
bioactivity, and the SLanc hydrogel itself can activate VEGF
receptors to a similar degree as exogenously added growth
factor. Subcutaneous injection of the SLanc hydrogel results in
mature blood vessels containing an endothelial cell lining, an α-
SMA muscle layer, and pericytes located within SLanc implants
(Figure 8A,B).30 In a subsequent injury model of hind-limb
ischemia, the femoral artery of mice was ligated to prevent
blood ﬂow, and SLanc peptide was injected into the quadricep
and gastrocnemius muscles 24 h later. It was shown that this
peptide aided in the resolution of hind-limb ischemia, as
animals injected with this peptide exhibited a higher perfusion
ratio of blood in the ischemic limb and increased treadmill
distance running compared with control animals.31
We hypothesize that protein-mimicking peptides, such as
SLanc, may be able to more robustly drive biological processes
than exogenously added growth factor because they present a
signiﬁcantly higher concentration of bioactive signal. Typically,
scaﬀolds used for angiogenesis are loaded with exogenous
VEGF at concentrations in the nanomolar range; SLanc,
however, presents the bioactive mimic at concentrations in the
millimolar range.30 Economic feasibility prevents delivery of
exogenous growth factor at these concentrations. However,
while commercial purchasing of growth factors is rather costly,
the cost of including additional amino acids during MDP
synthesis is practically negligible. Additionally, as described
earlier, growth factors diﬀuse out of the MDP; in contrast,
when the signal is actually contained in the MDP hydrogel
itself, the signal remains localized until the material degrades.
The success of SLanc suggests that through engineering of the
MDP primary sequence we are able to drive speciﬁc cellular
processes.
Including biomimics into the MDP primary sequence oﬀers a
cost-eﬀective method of driving speciﬁc biological responses.
We have previously investigated cell adhesion, material
degradation, and angiogenesis, but MDPs can be used to
drive any process for which a mimic exists. New biological
mimic sequences are consistently being identiﬁed in the
literature, and MDP-mimic hydrogels could be explored for
potential use in other applications such as wound healing,
resolution of chronic inﬂammation, and neural development.
The biological studies performed on MDPs have included in
vitro, ex vivo, and in vivo analyses. The response to the MDP,
molecules delivered by the MDP, or bioactive sequences
incorporated into the primary sequence diﬀers drastically
depending on the environment. For instance, in vitro studies
suggest that incorporation of an enzymatic cleavage motif is
necessary for cellular inﬁltration of the scaﬀold.16 In contrast,
hydrogels with or without inclusion of the enzymatic cleavage
domain are rapidly populated with cells in in vivo studies.23,28,30
Although in vivo cellular inﬁltration appears to be independent
of this motif, the rate of material degradation appears to occur
Figure 8. (A) Schematic showing inﬁltration of cells and blood vessel
formation after subcutaneous injection of the SLanc hydrogel. (B)
Immunohistochemical analysis of the SLanc implant 7 days after
injection. Smooth muscle cells appear red (αSMA+), pericyte-like cells
appear purple (Nestin+), and endothelial cells appear green (CD31+).
Adapted from ref 30. Copyright 2015 American Chemical Society.
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much more rapidly when the motif is present. We speculate
that the immune and vascular systems are imperative for
deﬁning the interaction between cells and our material. This
hypothesis is supported through ex vivo experiments, where the
MDP appears biocompatible but not highly interactive with
native tissue.20 While ex vivo studies maintain the complexity of
tissue architecture, they lack systemic inﬂuences by the immune
or vascular systems, suggesting that these systems are key
players in deﬁning in vivo results.
■ CONCLUSION AND FUTURE OUTLOOK
As a versatile and highly customizable material, MDPs can be
tailored to suit a wide range of biological applications. By
altering the amino acid composition of the peptide used for
hydrogel formation, it is possible to deﬁne the chemical,
mechanical, and biological properties of the MDP hydrogel.
Through the incorporation of multiple bioactive domains, it is
possible to create a “smart” scaﬀold capable of communicating
with the biological environment in a complex manner. Ideally,
these materials will be able to both respond to cellular signals
and inﬂuence cell behavior. As biologists gain greater
understanding of speciﬁc signaling pathways, the molecules
involved in these signaling pathways, and the bioactive portions
of these molecules, chemists will be able to better design
peptide-based materials capable of inﬂuencing these pathways.
Through an interdisciplinary eﬀort of chemists, biologists, and
materials scientists, peptide-based materials have great potential
to improve drug delivery and tissue regeneration eﬀorts.
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